You have 9 free searches left this month | for more free features.

encorafenib

Showing 1 - 25 of 39

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Metastatic Colorectal Cancer Trial in Houston (Cetuximab, Ulixertinib, Encorafenib)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • Houston, Texas
    M D Anderson Cancer Center
Aug 9, 2023

Metastatic Colorectal Cancer Trial (ZN-c3, Encorafenib, Cetuximab)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • (no location specified)
Feb 15, 2023

Solid Tumor Trial in Toronto (Binimetinib, Encorafenib)

Recruiting
  • Solid Tumor
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Sep 23, 2022

Metastatic Colorectal Adenocarcinoma, Refractory Colorectal Adenocarcinoma, Stage IV Colorectal Cancer AJCC v8 Trial (drug,

Not yet recruiting
  • Metastatic Colorectal Adenocarcinoma
  • +2 more
  • BET Bromodomain Inhibitor ZEN-3694
  • +6 more
  • (no location specified)
Oct 25, 2023

Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma, Pathologic Stage IV Cutaneous Melanoma AJCC v8 Trial in

Recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 9, 2022

Melanoma Trial in Worldwide (encorafenib, binimetinib, pembrolizumab)

Recruiting
  • Melanoma
  • encorafenib
  • +4 more
  • Siena, Toscana, Italy
  • +11 more
Jun 23, 2023

Colon Adenocarcinoma, Microsatellite Stable Colon Carcinoma, Stage IIB Colon Cancer AJCC v8 Trial (drug, biological, procedure,

Not yet recruiting
  • Colon Adenocarcinoma
  • +4 more
  • Encorafenib
  • +5 more
  • (no location specified)
Jan 24, 2023

BRAF NP_004324.2:p.V600M, BRAF V600E Mutation Present, Metastatic Thyroid Gland Carcinoma Trial in Portland (Binimetinib,

Recruiting
  • BRAF NP_004324.2:p.V600M
  • +6 more
  • Portland, Oregon
    Providence Portland Medical Center
Aug 17, 2022

BRAF V600E Unresectable or Metastatic Melanoma, BRAF V600E Metastatic NSCLC, Melanoma Trial in Guangzhou (Encorafenib)

Completed
  • BRAF V600E Unresectable or Metastatic Melanoma
  • +2 more
  • Encorafenib
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Jun 9, 2022

Metastatic Colon Adenocarcinoma, Metastatic Colorectal Adenocarcinoma, Metastatic Microsatellite Stable Colorectal Carcinoma

Terminated
  • Metastatic Colon Adenocarcinoma
  • +27 more
  • San Francisco, California
  • +1 more
Jan 5, 2023

Metastatic Malignant Tumor in the Brain, Metastatic Melanoma, Stage III Cutaneous Melanoma AJCC v7 Trial in Houston (drug,

Active, not recruiting
  • Metastatic Malignant Neoplasm in the Brain
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 15, 2022

Melanoma Trial in Pittsburgh (encorafenib, nivolumab, ipilimumab)

Recruiting
  • Melanoma
  • encorafenib
  • +3 more
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Mar 24, 2022

Colorectal Cancer, GIST Trial (DCC-3116, Ripretinib, Cetuximab)

Not yet recruiting
  • Colorectal Cancer
  • GIST
  • (no location specified)
Jul 14, 2023

Cancer Trial in Melbourne (Trametinib, Cobimetinib, Binimetinib)

Recruiting
  • Cancer
  • Melbourne, Victoria, Australia
    Peter MacCallum Cancer Centre
Nov 4, 2022

Metastatic Colorectal Cancer Trial in Oslo (Alectinib, Cetuximab, Crizotinib)

Recruiting
  • Metastatic Colorectal Cancer
  • Oslo, Norway
    Oslo University Hospital
Feb 10, 2023

Melanoma, Glioma, Thyroid Cancer Trial (PF-07799544, PF-07284890, PF-07799933)

Not yet recruiting
  • Melanoma
  • +6 more
  • (no location specified)
Sep 9, 2022

Malignant Melanoma Trial in Herlev, Aarhus, Odense (Pembrolizumab Injection [Keytruda], Ipilimumab Injection [Yervoy], Nivolumab

Recruiting
  • Malignant Melanoma
  • Pembrolizumab Injection [Keytruda]
  • +6 more
  • Herlev, Hovedstaden, Denmark
  • +2 more
Sep 16, 2022

Metastatic Melanoma, Brain Metastases Trial in Spain (encorafenib, binimetinib, Whole brain radiation therapy)

Recruiting
  • Metastatic Melanoma
  • Brain Metastases
  • encorafenib
  • +3 more
  • Palma De Mallorca, Baleares, Spain
  • +20 more
Feb 16, 2022

BRAF V600E, Metastatic Colorectal Cancer Trial in China (Encorafenib, Cetuximab, FOLFIRI)

Recruiting
  • BRAF V600E
  • Metastatic Colorectal Cancer
  • Encorafenib
  • +2 more
  • Beijing, Beijing, China
  • +33 more
Dec 20, 2022

NSCLC Trial in China, Taiwan (Encorafenib, Binimetinib)

Recruiting
  • Non-Small Cell Lung Cancer
  • Beijing, China
  • +35 more
Jun 29, 2022

Malignant Melanoma, Metastatic Melanoma, Immunotherapy Trial (Pembrolizumab, Encorafenib, Binimetinib)

Not yet recruiting
  • Malignant Melanoma
  • +4 more
  • (no location specified)
Mar 31, 2022

BRAF V600E-mutant Metastatic Colorectal Cancer Trial in Worldwide (encorafenib, Binimetinib, Cetuximab)

Active, not recruiting
  • BRAF V600E-mutant Metastatic Colorectal Cancer
  • encorafenib
  • +2 more
  • New York, New York
  • +44 more
Aug 8, 2022

Targeted Therapies in BRAF Positive Metastatic Melanoma in US

Active, not recruiting
  • Melanoma
  • Encorafenib
  • +5 more
  • New York, New York
    Pfizer Investigational Site
Feb 18, 2022

Melanoma, Metastasis Trial in Melbourne (Binimetinib, Encorafenib, Palbociclib)

Recruiting
  • Melanoma
  • Metastasis
  • Melbourne, Victoria, Australia
    Peter MacCallum Cancer Centre
Jan 19, 2021

Solid Tumors, GI Cancer Trial in Taiwan, United States (CGX1321, Pembrolizumab, encorafenib)

Recruiting
  • Solid Tumors
  • GI Cancer
  • Long Beach, California
  • +25 more
Jan 11, 2022